Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-82472 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-82472, RRID:AB_11020659
- Product name
- Rabbit Polyclonal Periostin/OSF-2 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Specificity of human Periostin/OSF-2 antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. This antibody is pan specific for all splice variants of Periostin/OSF-2.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Expression of Periostin in Cancer-associated Fibroblasts in Mammary Cancer in Female Dogs.
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.
Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform.
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
Borecka P, Ratajczak-Wielgomas K, Ciaputa R, Kandefer-Gola M, Janus I, Piotrowska A, Kmiecik A, Podhorska-Okolów M, Dzięgiel P, Nowak M
In vivo (Athens, Greece) 2020 May-Jun;34(3):1017-1026
In vivo (Athens, Greece) 2020 May-Jun;34(3):1017-1026
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.
Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DV, Byrom D, Cortina C, Morral C, Barceló C, Tosi S, Riera A, Attolini CS, Rossell D, Sancho E, Batlle E
Nature genetics 2015 Apr;47(4):320-9
Nature genetics 2015 Apr;47(4):320-9
Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform.
Gbormittah FO, Haab BB, Partyka K, Garcia-Ott C, Hancapie M, Hancock WS
Journal of proteome research 2014 Jan 3;13(1):289-99
Journal of proteome research 2014 Jan 3;13(1):289-99
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
Edlund K, Lindskog C, Saito A, Berglund A, Pontén F, Göransson-Kultima H, Isaksson A, Jirström K, Planck M, Johansson L, Lambe M, Holmberg L, Nyberg F, Ekman S, Bergqvist M, Landelius P, Lamberg K, Botling J, Ostman A, Micke P
International journal of cancer 2012 Nov 15;131(10):2264-73
International journal of cancer 2012 Nov 15;131(10):2264-73
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: Periostin/OSF-2 Antibody [NBP1-82472] - Analysis in human cell line RT-4, human cell line U-251 MG, human plasma, human liver tissue and human tonsil tissue.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Periostin/OSF-2 Antibody [NBP1-82472] - Staining of human pancreas shows low expression as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Periostin/OSF-2 Antibody [NBP1-82472] - Staining of human skin shows high expression.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Periostin/OSF-2 Antibody [NBP1-82472] - Staining in human skin and pancreas tissues using anti-POSTN antibody. Corresponding POSTN RNA-seq data are presented for the same tissues.
